Healthcare Global Enterprises Ltd share price today: ₹649.00 | Next market-day median forecast: ₹551.65 (2026-07-13) | 10–90% range: ₹551.65–₹572.93 | Forecast confidence: 93.2% | Chance of upside: 0.0% | Intrinsic value: ₹241.80 | 2027 target: ₹668.44 | 2036 target: ₹660.97
The next market-day median forecast for Healthcare Global Enterprises Ltd (2026-07-13) is ₹551.65 which is 15.00% lower than today’s share price of ₹649.00 with a 10–90% range of ₹551.65–₹572.93. The estimate uses available price history, volatility, trend behaviour and intrinsic value gap.
Interactive Share Price Forecast
Choose tomorrow, day after, weekly, monthly or custom trading-day horizons and adjust assumptions to view possible price ranges.
Scenario controls
Uses trading-day intervals for short-term and long-term forecast views.
1 = next market day, 2 = day after, 21 ≈ one trading month.
Scenario adjusts assumptions for cautious, normal or optimistic market conditions.
Wider bands show more uncertainty; narrower bands show central outcomes.
Higher volatility widens the forecast range.
Higher influence gives more weight to intrinsic value in the forecast.
Target date--
Median forecast--
Expected return--
Selected range--
Chance of upside--
Confidence--
Horizon
Target date
Median forecast
Range
Return
Chance of upside
Forecast guide: Explore possible future price ranges using available price history, intrinsic value trend, volatility and valuation gap. Estimates update as fresh market and valuation data become available.
Healthcare Global Enterprises Ltd – Investor Insights
Valuation StatusiCompares the stock's intrinsic value (calculated from fundamentals like earnings, book value, and growth) with the current market price (CMP). Undervalued = potential buying opportunity. Overvalued = the market may be pricing in too much optimism.
Overvalued
Intrinsic ₹241.80 vs CMP ₹649.00 (-62.7%)
Market RegimeiShows whether the stock is in an uptrend (bullish) or downtrend (bearish) based on its Exponential Moving Average (EMA). When price is above EMA → bullish momentum. Below EMA → bearish pressure. This affects how our model adjusts volatility and predictions.
● Neutral
Price/EMA: 1.073 · EMA(252): ₹604.79
VolatilityiMeasures how much the stock price swings. Low (<25%) = stable, predictable price movement. Moderate (25-40%) = normal for most stocks. High (>40%) = large daily swings, higher risk. The "recent trend" shows if volatility is currently increasing or decreasing compared to its historical average.
34.8% annualized
Risk: Moderate · Recent trend: Stable
Trend MemoryiThe Hurst Exponent measures whether price movements tend to continue (trending) or reverse (mean-reverting). Above 0.55 = momentum persists, recent trends likely to continue. Below 0.45 = price tends to snap back after big moves. Around 0.5 = random walk, past moves don't predict future direction.
Random walk
Hurst exponent: 0.452
Projected CAGRiCompound Annual Growth Rate — the average yearly return if the stock reaches our projected price target. 5Y and 10Y show different time horizons. Higher CAGR = faster expected growth. Negative CAGR = the model projects the stock may decline from current levels.
+1.9%5Y+0.2%10Y
Historical drift: +16% annualized
Risk-Reward RatioiCompares your potential upside (to intrinsic value) against potential downside (to fundamental floor). Above 2x = favorable risk-reward, potential gain is at least double the potential loss. Below 1x = unfavorable, you risk losing more than you could gain. A negative value means the stock is already above intrinsic value.
-0.64x
Upside -62.7% vs downside 97.7% · Unfavourable
Margin of SafetyiA concept from value investing (Benjamin Graham). It measures how much cheaper the stock is compared to its intrinsic value. Positive margin = you're buying below fair value (safety cushion). Negative margin = you're paying more than the stock is fundamentally worth. Most value investors look for at least 15-25% margin of safety.
-168.4%
No margin
Forecast ConfidenceiShows how strongly the forecast is supported by available data, recent forecast behaviour and volatility. Higher confidence means the estimate has better historical support and lower uncertainty.
High (93.2%)
Chance of upside: 0.0% · Avg forecast error: 1.7% · 586 data points
Fundamental FlooriThe lowest price the stock is expected to reach under normal market conditions, based on book value and financial strength (ROE, ROCE, debt ratios). A very low floor relative to CMP means the company has limited tangible asset backing at current prices. In extreme market crashes, prices can temporarily breach this level.
₹15.06
(97.7% below CMP)
52-Week Range
iShows the stock's lowest and highest closing prices over the past year (~252 trading days). The marker shows where today's price sits within that range. Near the low = potential value opportunity or ongoing weakness. Near the high = momentum or possible overextension.
₹522.00
₹776.00
CMP: ₹649.0050% into range16.4% below 52W high
Monthly Return DistributioniBased on historical monthly returns (~21 trading days per month). Shows how many months the stock went up vs down, the best and worst single-month returns, and the win rate. A win rate above 55% with a positive average return indicates consistent performance. High best/worst spread = volatile returns.
Convergence TimelineiShows a possible timeline for the stock price to move closer to its intrinsic value. Milestones show estimated prices at 25%, 50%, 75% and 100% convergence. For overvalued stocks, convergence may indicate downside toward intrinsic value.
Target: ₹241.80 in ~5.0 years (2031)
Now ₹64925% ₹54750% ₹44575% ₹344Target ₹242
Gap: 62.7% downward · Assumed convergence period: 5.0 years
What this means: Healthcare Global Enterprises Ltd appears overvalued by 62.7% relative to intrinsic value. The stock is in a neutral regime. Volatility is moderate (34.8% annualized).
Healthcare Global Enterprises Ltd Year-Wise Share Price Target (2027–2036)
Year
Projected Price (₹)
Growth %
CAGR
2027
668.44
+3.0%
+3.0%
Month
Projected Price (₹)
Jan
653.86
Feb
657.10
Mar
659.57
Apr
658.17
May
667.37
Jun
663.01
Jul
658.13
Aug
663.61
Sep
663.11
Oct
665.92
Nov
671.87
Dec
668.44
2028
687.51
+5.9%
+2.9%
Month
Projected Price (₹)
Jan
663.28
Feb
671.65
Mar
665.72
Apr
669.53
May
671.49
Jun
671.72
Jul
673.29
Aug
681.37
Sep
680.97
Oct
675.73
Nov
685.31
Dec
687.51
2029
687.24
+5.9%
+1.9%
Month
Projected Price (₹)
Jan
694.30
Feb
698.15
Mar
697.99
Apr
689.04
May
696.62
Jun
693.72
Jul
692.96
Aug
691.86
Sep
694.39
Oct
684.52
Nov
686.73
Dec
687.24
2030
697.35
+7.4%
+1.8%
Month
Projected Price (₹)
Jan
692.29
Feb
693.51
Mar
691.69
Apr
692.79
May
701.25
Jun
699.58
Jul
703.36
Aug
706.09
Sep
708.03
Oct
703.26
Nov
710.12
Dec
697.35
2031
711.94
+9.7%
+1.9%
Month
Projected Price (₹)
Jan
699.95
Feb
705.21
Mar
707.49
Apr
709.52
May
709.12
Jun
709.95
Jul
700.69
Aug
702.85
Sep
695.82
Oct
703.14
Nov
710.85
Dec
711.94
2032
679.91
+4.8%
+0.8%
Month
Projected Price (₹)
Jan
694.01
Feb
692.49
Mar
688.15
Apr
687.82
May
682.36
Jun
682.00
Jul
685.00
Aug
686.11
Sep
687.88
Oct
685.10
Nov
683.45
Dec
679.91
2033
690.60
+6.4%
+0.9%
Month
Projected Price (₹)
Jan
687.95
Feb
684.65
Mar
694.20
Apr
701.72
May
701.92
Jun
705.79
Jul
704.80
Aug
702.72
Sep
704.86
Oct
704.39
Nov
697.43
Dec
690.60
2034
669.80
+3.2%
+0.4%
Month
Projected Price (₹)
Jan
682.29
Feb
679.41
Mar
678.37
Apr
679.45
May
675.22
Jun
665.63
Jul
669.95
Aug
670.93
Sep
669.15
Oct
669.65
Nov
670.09
Dec
669.80
2035
660.44
+1.8%
+0.2%
Month
Projected Price (₹)
Jan
671.33
Feb
667.96
Mar
664.66
Apr
663.54
May
674.27
Jun
670.81
Jul
667.52
Aug
667.92
Sep
668.92
Oct
654.72
Nov
648.34
Dec
660.44
2036
660.97
+1.8%
+0.2%
Month
Projected Price (₹)
Jan
663.86
Feb
660.75
Mar
663.86
Apr
666.26
May
656.51
Jun
656.31
Jul
654.03
Aug
662.20
Sep
657.81
Oct
658.72
Nov
660.52
Dec
660.97
Healthcare Global Enterprises Ltd Stock Price Analysis
Avg Error (MAPE)iMean Absolute Percentage Error — the average difference between predicted and actual prices, expressed as a percentage. Lower is better. Below 2% = excellent, 2-5% = good, above 5% = the model struggles with this stock.
2.49%
Direction AccuracyiHow often the model correctly predicted whether the price would go up or down the next day. Above 55% = good (better than a coin flip). Above 60% = strong. This matters more than exact price accuracy for trading decisions.
67.7%
Avg Error (₹)iThe average rupee difference between predicted and actual closing prices. For a ₹100 stock, an error of ₹2 means predictions are typically off by about 2%. This gives you a sense of the prediction's precision in absolute terms.
₹13.58
PredictionsiTotal number of daily forecasts available for this stock. More observations improve the reliability of accuracy metrics and trend comparison.
Will Healthcare Global Enterprises Ltd share price increase on the next market day?
Healthcare Global Enterprises Ltd median forecast is ₹551.65 on 2026-07-13, which is 15.00% lower than today’s price of ₹649.00. The 10-90% forecast range is ₹551.65 to ₹572.93. Forecast confidence is 93.2%, with probability-up estimate of 0.0%. This estimate uses Getaka’s price-history, valuation-gap and volatility framework.
What is the intrinsic value of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd intrinsic value is ₹241.80, which is 62.74% below the current price of ₹649.00. This suggests the stock is currently overvalued.
What is the share price target of Healthcare Global Enterprises Ltd in 2027?
Healthcare Global Enterprises Ltd share price target for 2027 is projected to reach ₹668.44 by year-end (range: ₹653.86 to ₹671.87), representing a 3.00% increase from the current price of ₹649.00.
What is the share price target of Healthcare Global Enterprises Ltd in 2028?
Healthcare Global Enterprises Ltd share price target for 2028 is projected to reach ₹687.51 by year-end (range: ₹663.28 to ₹687.51), representing a 5.93% increase from the current price of ₹649.00.
What is the share price target of Healthcare Global Enterprises Ltd in 2029?
Healthcare Global Enterprises Ltd share price target for 2029 is projected to reach ₹687.24 by year-end (range: ₹684.52 to ₹698.15), representing a 5.89% increase from the current price of ₹649.00.
Should I buy Healthcare Global Enterprises Ltd stock now?
Based on current analysis, Healthcare Global Enterprises Ltd appears to be a consider reviewing your position candidate. Intrinsic value is ₹241.80 vs CMP ₹649.00. Use this as a research input and match it with your risk profile, investment horizon and portfolio plan.
What is the fundamental floor price for Healthcare Global Enterprises Ltd?
The fundamental floor price for Healthcare Global Enterprises Ltd is ₹15.06, calculated from book value and financial strength metrics (ROE, ROCE, debt-to-equity, interest coverage). This is the theoretical minimum price under normal market conditions.
Healthcare Global Enterprises Ltd Share Price Prediction – How We Calculate the Targets
We calculate the share price targets for Healthcare Global Enterprises Ltd using a combined approach of Geometric Fractional Brownian Motion (GFBM) and the Exponential Moving Average (EMA) for trend analysis. This hybrid model incorporates historical price data, memory effects through the Hurst exponent, and dynamic regime shifts based on the stock's trends. Below are the detailed steps of how these projections are calculated.
Step 1: Calculate the Log Returns
The log returns measure the relative change in stock prices over time. It is calculated as follows:
The Hurst exponent measures the "memory" or persistence of the stock price movement. It is calculated as follows:
\[ H = \frac{\log(R/S)}{\log(n)} \]
Step 6: Project Future Share Prices Using GFBM and EMA
The future price of the stock is projected using a combined model of Geometric Fractional Brownian Motion (GFBM) and Exponential Moving Average (EMA) for trend-based regime switching.
Step 7: Predicting Tomorrow's Stock Price for Healthcare Global Enterprises Ltd
The next market-day price forecast uses price trend, volatility, valuation gap and regime adjustment. The displayed value is the median estimate, supported by a 10–90% uncertainty range.
Step 8: Projected Share Prices for the Next 10 Years
The projected share prices for the next 10 years are calculated using the combined GFBM and EMA model, taking into account historical growth, volatility, and market trends.
Conclusion
Our hybrid approach provides a realistic projection of share prices for Healthcare Global Enterprises Ltd over the next 10 years by considering historical performance, volatility, market memory, and current trends.
The projected stock prices are informational estimates based on available data and assumptions. Past performance does not guarantee future results. Investors should consider risk profile, investment horizon, portfolio allocation and market risks before acting on any research output. Please read all relevant documents and terms carefully before investing.